Beta-Blockers Prevent Cardiac Events in Japanese Patients with Myocardial Infarction

Circulation Journal

Volumn 68, Issue 1, 2004, Pages 59-67

  Ishikawa, Kinji ^a   Miyataka, Masaru ^a   Kimura, Akio ^a   Takeda, Norihiro ^a   Hirano, Yutaka ^a   Hayashi, Takahiro ^a   Kanamasa, Ken ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beta blockers; Myocardial infarction; Secondary prevention; Vasospastic angina

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; STROKE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; BLOOD UREA NITROGEN; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HEART RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0942298684     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.59     Document Type: Article

References (25)

1. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707-1714.
2. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371.
3. Gottlieb S, Goldbourt U, Boyko V, Harpaz D, Mandelzweig L, Khoury Z, et al. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel: A comparison between 1981-1983 and 1992-1994. Eur Heart J 2000; 21: 284-295.
4. McGovern PG, Jacobs DR Jr, Shahar E, Arnett DK, Folsom AR, Blackburn H, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota Heart Survey. Circulation 2001; 104: 19-24.
5. Woods KL, Ketley D, Lowy A, Agusti A, Hagn C, Kala R, et al. Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction: Towards an understanding of factors influencing clinical practice. Eur Heart J 1998; 19: 74-79.
6. Ryan TJ, Amman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-1030.
7. Ishikawa K, Miyataka M, Kanamasa K, Hayashi T, Takenaka T, Inoki T, et al. Retrospective analysis showing less cardiac events in post-myocardial infarction patients treated with metoprolol. Jpn Circ J 2000; 64: 358-364.
8. Ishikawa K, Miyataka M, Kanamasa K, Hayashi T, Takenaka T, Inoki T, et al. β-blockers reduce the incidence of cardiac events in post-myocardial infarction patients. Jpn Heart J 2000; 41: 279-294.
9. Ishikawa K, Kimura A, Taniwa T, Takenaka T, Hayashi T, Kanamasa K. Modification of treatment strategies over a period of 14 years has markedly reduced cardiac events among post-myocardial infarction patients. Circ J 2002; 66: 881-885.
10. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
11. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N, et al. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J 1996; 60: 779-788.
12. Ishikawa K, Nakai S, Takenaka T, Kanamasa K, Hama J, Ogawa I, et al. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Circulation 1997; 95: 2368-2373.
13. Ishikawa K, Kanamasa K, Hama J, Ogawa I, Takenaka T, Naito T, et al. Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Jpn Circ J 1997; 61: 38-45.
14. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, editor. Heart disease, 5th edn. Philadelphia: WB Saunders; 1997; 742-779.
15. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226-235.
16. Prichard BNC. β-adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol 1978; 5: 379-399.
17. Soriano JB, Hoes AW, Meems L, Grobbee DE. Increased survival with β-blockers: Importance of ancillary properties. Prog Cardiovasc Dis 1997; 39: 445-456.
18. i in ventricular myocytes compared with those of timolol and atenolol. Circ J 2003; 67: 83-90.
19. Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction: A placebo-controlled, randomized trial. Circulation 1997; 96: 183-191.
20. Wollert KC, Drexler H. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: Carvedilol as the sun and center of the β-blocker world? Circulation 2002; 106: 2164-2166.
21. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Exertional angina pectoris caused by coronary arterial spasm: Effects of various drugs. Am J Cardiol 1979; 43: 647-652.
22. Yasue H, Ogawa H, Okumura K. Coronary artery spasm in the genesis of myocardial ischemia. Am J Cardiol 1989; 63: 29E-32E.
23. Hjalmarson Å, Olsson G. Myocardial infarction: Effects of β-blockade. Circulation 1991; 84(Suppl VI): VI-101-VI-107.
24. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-1452.
25. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999; 99: 2829-2848.